As the Year of the Auspicious Snake ushers in renewal and prosperity, Beijing ZONCI Technology Development Co., Ltd. celebrates another joyful milestone — the official launch of its flagship innovation, the NOVA1000 Series Automatic Biochemical Analyzer (Registration No.: 京械注准20252220022). Alongside the analyzer, dozens of self-developed reagent kits have also been approved and are expected to be gradually introduced to the market in the first half of 2025.

A dazzling new star, extraordinary in every way. The NOVA1000 Series integrates ZONCI’s proprietary advanced detection technology, a fully automated testing platform, and an intelligent operating system. Paired with independently developed reagent kits, it delivers rapid and reliable biochemistry diagnostics. With superior speed and performance, it supports clinical decision-making across all hospital tiers, empowering precision medicine and safeguarding patient health.

Relentless innovation, continued recognition. With nearly two decades of deep involvement in the IVD industry, ZONCI has leveraged its robust technical foundation and strong R&D capabilities to continue specialize in the coagulation field while strategically expanding into biochemistry diagnostics. This marks a small step in product line expansion, but a major leap toward the company’s vision of advancing domestic substitution. Looking ahead, ZONCI will drive high-quality growth through continuous innovation and contribute fresh momentum to the development of the IVD industry.

ZONCI is always striving forward!